Our dilemma is presenting doctors with data/information about why irritant medications should infuse through a central line. We have the usual response of "we've been giving vanco for 20 years peripherally, we haven't seen much problems, or there's no evidence that it requires a central line" Some sources will say that vancomycin is an irritant and some will not. They aren't convinced by the list of irritant medications. Pharmacy does not recognize this list and feel their IV meds are peripherally compatible. Apparently the doctors are not seeing the phlebitis, infiltrations, multiple restarts, multiple sticks the patients experience when the veins get damaged with repeated irritant medication infusions, delayed medication administration times, poor venous status on subsequent hospitalizations, etc. Of course, we conveyed to them that we realize there may be comorbidities that would prohibit a central line, and we understand that. What would be a good way to gather/extract/organize the data? Our VAD team is not 24/7 so we cannot do all the tracking.